India to Uzbekistan: Levofloxacin Export Trade Route

The India to Uzbekistan Levofloxacin corridor is one of India's established pharmaceutical export routes, with 280 shipments documented worth a combined $5.8M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 20% of all export value, reflecting the consolidated nature of India's levofloxacin manufacturing sector.

Across 65 active suppliers, the average shipment value stands at $20.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with levofloxacin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 19.1%, placing it at rank #14 among India's top levofloxacin export destinations globally.

On the import side, key buyers of Indian levofloxacin in Uzbekistan include FE ADVANCE PHARMACEUTICAL BUSINESS, FE BARAKA DORI FARM, LLC , FE BARAKA DORI FARM LLC and 76 others. FE ADVANCE PHARMACEUTICAL BUSINESS is the single largest importer with 24 shipments valued at $1.4M USD.

India's levofloxacin exports to Uzbekistan are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 17 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 65 active exporters signals a competitive but concentrated market — buyers in Uzbekistan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, KUSUM HEALTHCARE PRIVATE LIMITED , KUSUM HEALTHCARE PRIVATE LIMITED — together account for 32% of total trade value on this route. The average shipment value of $20.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as drugs and pharmaceuticals harmless medicines levofloxacin tablets 500 mg and levoril n-1(levofloxacin intravenous infusion 0.5%w/vea.100ml con.(levofloxacinhemih.usp eq.to lev.500mg w.f.inj.usp q148260nos, suggesting that buyers in Uzbekistan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, FE ADVANCE PHARMACEUTICAL BUSINESS is the largest importer with 24 shipments worth $1.4M USD — representing 24% of all levofloxacin imports from India on this route. A total of 79 buyers are active on this corridor.